Literature DB >> 11375141

Management of severe Alzheimer's disease and end-of-life issues.

L Volicer1.   

Abstract

The quality of life of individuals with severe Alzheimer's disease requires attention to three main factors: (1) availability of meaningful activities, (2) optimal management of medical issues, and (3) appropriate treatment of psychiatric symptoms. Preservation of ambulation and comfort and avoidance of depression are significant interfaces between these three main factors. Formulation of an advance proxy plan is important for ensuring that the patient's previous wishes or best interests are considered when decisions about treatment strategies are made. Decisions regarding treatment strategies should take into consideration decreased effectiveness of several therapeutic approaches in this patient population. Hospice care is appropriate for the terminal stage of Alzheimer's disease, but palliative care also can be provided in other settings.

Entities:  

Keywords:  Death and Euthanasia

Mesh:

Year:  2001        PMID: 11375141     DOI: 10.1016/s0749-0690(05)70074-4

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  16 in total

Review 1.  Dependence as a unifying construct in defining Alzheimer's disease severity.

Authors:  Trent McLaughlin; Howard Feldman; Howard Fillit; Mary Sano; Frederick Schmitt; Paul Aisen; Christopher Leibman; Lisa Mucha; J Michael Ryan; Sean D Sullivan; D Eldon Spackman; Peter J Neumann; Joshua Cohen; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2010-11       Impact factor: 21.566

2.  Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection: a cross-national analysis.

Authors:  Robin L Kruse; David R Mehr; Jenny T van der Steen; Marcel E Ooms; Richard W Madsen; Ashley K Sherman; Ralph B D'Agostino; Gerrit van der Wal; Miel W Ribbe
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

3.  End-of-life care for persons with advanced Alzheimer disease: design and baseline data from the ALFINE study.

Authors:  F Nourhashémi; S Gillette; C Cantet; A Stilmunkes; N Saffon; M E Rougé-Bugat; B Vellas; Y Rolland
Journal:  J Nutr Health Aging       Date:  2012-05       Impact factor: 4.075

4.  Treating patients with moderate to severe Alzheimer's disease: implications of recent pharmacologic studies.

Authors:  Concetta M Forchetti
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

5.  Ethical issues in diagnosing and treating Alzheimer disease.

Authors:  Edmund G Howe
Journal:  Psychiatry (Edgmont)       Date:  2006-05

6.  The effect of a family therapy and technology-based intervention on caregiver depression.

Authors:  Carl Eisdorfer; Sara J Czaja; David A Loewenstein; Mark P Rubert; Soledad Argüelles; Victoria B Mitrani; José Szapocznik
Journal:  Gerontologist       Date:  2003-08

7.  Dying with dementia in long-term care.

Authors:  Philip D Sloane; Sheryl Zimmerman; Christianna S Williams; Laura C Hanson
Journal:  Gerontologist       Date:  2008-12

8.  The clinical course of advanced dementia.

Authors:  Susan L Mitchell; Joan M Teno; Dan K Kiely; Michele L Shaffer; Richard N Jones; Holly G Prigerson; Ladislav Volicer; Jane L Givens; Mary Beth Hamel
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

9.  Healthcare proxies of nursing home residents with advanced dementia: decisions they confront and their satisfaction with decision-making.

Authors:  Jane L Givens; Dan K Kiely; Kristen Carey; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2009-05-21       Impact factor: 5.562

10.  Prevalence and treatment of neuropsychiatric symptoms in advanced dementia.

Authors:  Karan S Kverno; Peter V Rabins; David M Blass; Kathryn L Hicks; Betty S Black
Journal:  J Gerontol Nurs       Date:  2008-12       Impact factor: 1.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.